Insider · CIK 0001358266

Yeramian Patrick D

Reports to the SEC for 2 companies · BOCA RATON, FL

sec.gov

Transactions

Companies

Filings

CIK

0001358266

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-01-09	AMLXAmylyx Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−2,812 sh	$16.33	−$45.9K	205,605
2023-05-15	AMLXAmylyx Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,201 sh	$0.37	+$814.37	210,618
2023-05-15	AMLXAmylyx Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,764 sh	$6.88	+$67.2K	220,382
2023-05-15	AMLXAmylyx Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−12K sh	$29.03	−$347K	208,417
2023-05-15	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,201 sh	—	—	15,404
2023-05-15	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,764 sh	—	—	33,770
2023-04-17	AMLXAmylyx Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+44.9K sh	$0.37	+$16.6K	253,278
2023-04-17	AMLXAmylyx Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,718 sh	$6.88	+$32.5K	257,996
2023-04-17	AMLXAmylyx Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−49.3K sh	$30.53	−$1.5M	208,717
2023-04-17	AMLXAmylyx Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−300 sh	$30.94	−$9,282	208,417
2023-04-17	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−44.9K sh	—	—	17,605
2023-04-17	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,718 sh	—	—	43,534
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−52.2K sh	$31.85	−$1.66M	152,088
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−2,416 sh	$32.43	−$78.4K	149,672
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc.A Award	Chief Medical Officer	AAward	+9,167 sh	—	—	158,839
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+41.3K sh	—	—	41,250
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,789 sh	$0.33	+$920.37	207,088
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+30K sh	$0.37	+$11.1K	237,129
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+16.7K sh	$6.88	+$115K	253,877
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−52.2K sh	$31.85	−$1.66M	201,666
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−2,416 sh	$32.43	−$78.4K	199,250
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc.A Award	Chief Medical Officer	AAward	+9,167 sh	—	—	208,417
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+41.3K sh	—	—	41,250
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,789 sh	—	—	0
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−30K sh	—	—	62,466
2023-03-16	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−16.7K sh	—	—	48,252
2023-01-06	AMLXAmylyx Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	+1,405 sh	$36.08	+$50.7K	204,928
2023-01-06	AMLXAmylyx Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	+629 sh	$36.79	+$23.1K	204,299
2022-01-06	AMLXAmylyx Pharmaceuticals, Inc.A Award	Chief Medical Officer	AAward	+28.3K sh	—	—	206,333
2022-01-06	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+128K sh	—	—	127,500

Recent filings

Accepted (ET)
Jan 114
Yeramian Patrick D0000950170-24-003974
SEC(opens sec.gov)
May 174
Yeramian Patrick D0000950170-23-022775
SEC(opens sec.gov)
Apr 194
Yeramian Patrick D0000899243-23-011461
SEC(opens sec.gov)
Mar 244/A
Yeramian Patrick D0000899243-23-009600
SEC(opens sec.gov)

Companies

Address

1815 PARKSIDE CIRCLE SOUTH

BOCA RATON, FL, 33486